investors.bioviepharma.com
BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid
Conference call scheduled for Tuesday, September 15, 2026, at 8:30 a.m. Eastern Time (ET) CARSON CITY, Nev., Sept. 14, 2026 (GLOBE NEWSWIRE) - BioVie Inc. (NASDAQ: BIVI) ("BioVie" or the "Company"), a...